• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Down0.10%

    Imprimis Pharmaceuticals, Inc. (IMMY)

    -NasdaqCM
    8.50 Up 0.10(1.17%) 10:31AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 1,660   10   100  
    Cost of Revenue1,093   -   -  
    Gross Profit 567   10   100  
    Operating Expenses
    Research Development237  1,616  1,299  
    Selling General and Administrative10,477  6,081  2,980  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (10,147) (7,687) (4,179)
    Income from Continuing Operations
    Total Other Income/Expenses Net32  44  (1,180)
    Earnings Before Interest And Taxes(10,114)(7,643)(4,163)
    Interest Expense4   -  25  
    Income Before Tax(10,118)(7,643)(4,188)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(10,118)(7,643)(5,384)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (10,118) (7,643) (5,384)
    Preferred Stock And Other Adjustments -   -  (200)
    Net Income Applicable To Common Shares (10,118) (7,643) (5,584)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.